Our Strategy
Our Strategy
Achieve operational excellence that consistently produces efficient & effective products & services
| Initiative | Target | IR 2023 | IR 2024 | Progress Apr 2024 – Mar 2025 |
|---|---|---|---|---|
| Modernise ERP/SAP systems |
|
|
|
|
Product Compliance to the Standards (Ensuring that patients receive products of the highest quality) |
|
|
|
|
% Red cells issues vs red cells ordered |
|
|
|
|
Wastage – % of blood discarded |
|
|
|
|
Build administrative rigour in all processes
| Initiative | Target | IR 2023 | IR 2024 | Progress Apr 2024 – Mar 2025 |
|---|---|---|---|---|
| Debtors’ days |
|
|
|
|
Provision for credit losses as a % of Revenue |
|
|
|
|
Gross Revenue as a % of budget |
|
|
|
|
| Surplus % of revenue overall measure for profitability |
|
|
|
|
ICT SLA Performance |
|
|
|
|
| Net cash reserves |
|
|
|
|
| Business Continuity Management (BCM) |
|
|
|
|
| Employee cost as a % of total costs |
|
|
|
|